SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU) - moderated
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: ladyPI who wrote (49399)1/20/2019 4:21:02 PM
From: immuapproval  Read Replies (1) of 63276
 
The immu grand slam homerun has Failed. There will be no 132 sold in 2019. Heck any response to a CRL takes greater than twelve months regardless of the cause. AA is gone and the valuation of immu is now less. It was certainly worth the risk to take but it failed. Now the landscape and valuation are very different. Pehl et al failed and maybe it was not his/their fault and maybe it was delaying by FDA. At this point it really is of no matter. But now you have 90-100 sales employees with nothing to do. Not to belabor the past mistakes but hiring 100 sales employees BEFORE FDA approval probably did not seem kosher to any inspectors who had questions about CMC/ process. Regardless now actually is the time for a sale BUT Houston we have a problem on what we can now get. Why you ask because the valuation/ 5 billion cap/ 28 per share was based on a "slam dunk AA approval". IF the deficiency can be CLEARLY defined maybe a big pharma can maybe do 30-35 if it can see the value in competent hands. I am stunned that immu held 13 on options expiration Friday. I had sold 250 12puts and the open 12 put interest was huge. Got lucky they were not assigned. This stock is going lower. I hope Behzad can put his EGO aside, accept the loss and just kick it like all good traders have to do when confronted with Failure. The real Crime here is that the FDA cares so little about unmet medical need TNBC patients that they could not be bothered to convey any known deficiencies before their little catch-all CRL.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News